Kino Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 11, 2019 at 12:27 pm
Share
Kino Biotech Co., Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 202.835 million compared to TWD 133.068 million a year ago. Operating loss was TWD 7.611 million compared to operating Income of TWD 5.860 million a year ago. Net loss was TWD 10.048 million compared to net income of TWD 2.855 million a year ago. Basic loss per share was TWD 0.41 compared to basic earnings per share of TWD 0.13 a year ago. For the nine months, sales was TWD 557.464 million compared to TWD 396.782 million a year ago. Operating loss was TWD 29.018 million compared to TWD 13.795 million a year ago. Net loss was TWD 34.272 million compared to TWD 5.580 million a year ago. Basic loss per share was TWD 1.41 compared to TWD 0.28 a year ago.
Raku Co Ltd, formerly Kino Biotech Co., Ltd., is a Singapore-based company. The Company is an integrated bio-nutraceutical and cosmeceutical company. The Company is focused on product conceptualization, development, commercialization, brand marketing, sale and distribution of healthcare and beauty products. The Company provides healthcare and beauty products and services through brands, including Kinohimitsu, Activa and Xpertise. It has over two logistic and distribution centers in Malaysia and China. The Company provides products to China, Singapore, Malaysia, Vietnam, Thailand and Indonesia.
RAKU CO., LTD 
